£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Cancer Supportive Care Drugs Outlook 2023-2028 Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 88 days · 88 data points

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 01 September 2026 23 September 2026 15 October 2026 06 November 2026
View at Amazon ↗

Price data checked 3 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 88 days • 1 price levels

Days at Price
88 days 0 22 44 66 88 £520 Days at Price

Price Analysis

Most common price: £520 (88 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 88 days

Description

This specialized study provides a detailed outlook for cancer supportive care drugs in the United States from 2023 to 2028. The report focuses on latent demand, measured in millions of U.S. dollars, also known as potential industry earnings (P.I.E.) estimates. Data is provided across approximately 12,600 cities throughout the United States. For every city included, the report details the percent share that city holds in relation to its state and the country as a whole. These comparative benchmarks help readers evaluate specific cities against others quickly. This econometric statistical approach serves as a practical tool for developing effective distribution and sales force strategies.

Key Features

Provides latent demand outlook for cancer supportive care drugs in the United States through 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars.

Covers data for approximately 12,600 cities across the United States.

Reports the percent share of each city relative to its state and the entire United States.

Offers comparative benchmarks to help gauge city performance against others.

Utilizes an econometric statistical approach to support distribution and sales force strategies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

India Cancer Supportive Care Drugs Outlook 2023-2028
99% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
99% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
99% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 23 Sep 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
99% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan

£495.00 02 Oct 2026
2023-2028 US Cancer Screening Outlook - Market Study
98% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
98% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 31 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
98% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
98% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
98% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 02 Nov 2026
World Outlook for Cancer Therapies 2025-2030 Report
98% match

World Outlook for Cancer Therapies 2025-2030 Report

Price unavailable
Cancer Therapy Outlook 2016-2021 - North America & Caribbean
98% match

Cancer Therapy Outlook 2016-2021 - North America & Caribbean

£425.00 08 Nov 2026
The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
98% match

The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

£795.00 02 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
98% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 06 Nov 2026
Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
98% match

Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study

£425.00 07 Nov 2026
Cancer Diagnostics Lab Test Outlook in India 2023-2028
98% match

Cancer Diagnostics Lab Test Outlook in India 2023-2028

£515.00 02 Nov 2026
The 2016 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
98% match

The 2016 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

£995.00 24 Oct 2026
World Outlook for Cancer Specialty Hospitals 2025-2030
98% match

World Outlook for Cancer Specialty Hospitals 2025-2030

Price unavailable
Targeted Therapy Liver Cancer Drugs Outlook 2023-2028
98% match

Targeted Therapy Liver Cancer Drugs Outlook 2023-2028

£520.00 06 Nov 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
98% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 27 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 01 Oct 2026
Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028
98% match

Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028

£515.00 07 Nov 2026